Literature DB >> 17196874

Fibroblasts and myofibroblasts: their source, function and role in disease.

Robin J McAnulty1.   

Abstract

Fibroblasts are found in most tissues of the body. They exhibit several phenotypes including non-contractile fibroblasts, contractile myofibroblasts, and intermediate phenotypes including the protomyofibroblast. Fibroblasts are metabolically active cells which play critical roles regulating extracellular matrices, interstitial fluid volume and pressure, and wound healing. Fibroblast numbers can be maintained or expanded by proliferation of resident populations but in addition, recent evidence indicates they can also be derived through epithelial-mesenchymal transition or from circulating and tissue-derived mesenchymal stem cells. Many diseases are associated with dysregulation of the injury repair response and fibroblast function, leading to increased or decreased deposition of extracellular matrix proteins, altered tissue architecture, impaired function and in some cases significant morbidity and mortality. There are currently no specific therapies that target fibroblast-associated pathology but increasing knowledge of pathological mechanisms has led to development of new agents providing hope for improved treatment of these diseases.

Entities:  

Mesh:

Year:  2006        PMID: 17196874     DOI: 10.1016/j.biocel.2006.11.005

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  140 in total

1.  MicroRNA signature in diabetic wound healing: promotive role of miR-21 in fibroblast migration.

Authors:  R Madhyastha; H Madhyastha; Y Nakajima; S Omura; M Maruyama
Journal:  Int Wound J       Date:  2011-11-09       Impact factor: 3.315

Review 2.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

Review 3.  Fibrotic response of tissue remodeling in COPD.

Authors:  Lina María Salazar; Ana Milena Herrera
Journal:  Lung       Date:  2011-02-02       Impact factor: 2.584

4.  Modulation of type II TGF-β receptor degradation by integrin-linked kinase.

Authors:  Linda Vi; Stellar Boo; Samar Sayedyahossein; Randeep K Singh; Sarah McLean; Gianni M Di Guglielmo; Lina Dagnino
Journal:  J Invest Dermatol       Date:  2014-09-30       Impact factor: 8.551

5.  Interleukin-10 Inhibits Bone Marrow Fibroblast Progenitor Cell-Mediated Cardiac Fibrosis in Pressure-Overloaded Myocardium.

Authors:  Suresh K Verma; Venkata N S Garikipati; Prasanna Krishnamurthy; Sarah M Schumacher; Laurel A Grisanti; Maria Cimini; Zhongjian Cheng; Mohsin Khan; Yujia Yue; Cindy Benedict; May M Truongcao; Joseph E Rabinowitz; David A Goukassian; Douglas Tilley; Walter J Koch; Raj Kishore
Journal:  Circulation       Date:  2017-06-30       Impact factor: 29.690

6.  CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model.

Authors:  Chang H Lee; Bhranti Shah; Eduardo K Moioli; Jeremy J Mao
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

7.  Non-linear micromechanics of soft tissues.

Authors:  Huan Chen; Xuefeng Zhao; Xiao Lu; Ghassan Kassab
Journal:  Int J Non Linear Mech       Date:  2013-11       Impact factor: 2.985

8.  Peritoneal Dialysis Fluid and Some of Its Components Potentiate Fibrocyte Differentiation.

Authors:  Sarah E Herlihy; Hannah E Starke; Melisa Lopez-Anton; Nehemiah Cox; Katayoon Keyhanian; Donald J Fraser; Richard H Gomer
Journal:  Perit Dial Int       Date:  2015-10-22       Impact factor: 1.756

9.  Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression?

Authors:  Eva A Turley; Mandana Veiseh; Derek C Radisky; Mina J Bissell
Journal:  Nat Clin Pract Oncol       Date:  2008-03-18

10.  Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum.

Authors:  S John Curnow; Marianne Fairclough; Caroline Schmutz; Steve Kissane; Alastair K O Denniston; Kate Nash; Christopher D Buckley; Janet M Lord; Mike Salmon
Journal:  PLoS One       Date:  2010-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.